Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018
Role of thrombin-activatable fibrinolysis inhibitor in lipopolysaccharide-induced acute lung injury Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury Source: Eur Respir J 2008; 31: 633-644 Year: 2008
Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment Source: Eur Respir J 2012; 40: 416-423 Year: 2012
Inhibition of acute lung inflammation by removal of pulmonary intravascular macrophages (PIMs) Source: Eur Respir J 2001; 18: Suppl. 33, 79s Year: 2001
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006
Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006
The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury Source: Eur Respir J 2008; 32: 862-870 Year: 2008
Prophylactic neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014
Dynamic changes of markers of endothelial function, hemostasis, fibrinolysis and inflammation in hospitalized patients with community-acquired pneumonia Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019
Human protein C concentrate administration reduces inflammation and apoptosis in lung after experimental sepsis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005
Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling Source: Eur Respir Rev 2008; 17: 130-137 Year: 2008
Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008
High-stretch, but not atelectasis, causes systemic cytokine release by lung-marginated monocytes Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Suppression of endotoxin-induced inflammation by taxol Source: Eur Respir J 2007; 30: 429-435 Year: 2007
Cardiopulmonary effects of iloprost in experimental acute lung injury Source: Eur Respir J 2005; 25: 81-87 Year: 2005
Changes in the vascular platelet phase of hemostasis in patients with septic and traumatic shock, presenting ARDS Source: Eur Respir J 2004; 24: Suppl. 48, 264s Year: 2004
Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis Year: 2007